Nextage Therapeutics Ltd (TLV:NXTG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 97.20
+2.90 (3.08%)
Jun 26, 2025, 5:24 PM IDT
Nextage Therapeutics Revenue
In the year 2024, Nextage Therapeutics had annual revenue of 413.00K ILS, down -52.85%.
Revenue
413.00K
Revenue Growth
-52.85%
P/S Ratio
79.31
Revenue / Employee
13.32K
Employees
31
Market Cap
32.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 413.00K | -463.00K | -52.85% |
| Dec 31, 2023 | 876.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 91.00K | -100.00K | -52.36% |
| Dec 31, 2020 | 191.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 61.87B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| BrainsWay | 161.81M |
| Ilex Medical | 922.08M |
| Novolog (Pharm-Up 1966) | 2.07B |
| SofWave Medical | 235.09M |